32 Lots Of Blood Pressure Drug Losartan Recalled Over Small Amounts Of Carcinogens

Losartan, which is proved by Macleods Pharmaceuticals Limited, is being recalled over trace amounts of a probably carcinogen. 32 lots are being recalled due to containing N-nitrosodiethylamine or NDEA according to the company notice that was published to the FDA website on Wednesday.
The recall notice states, “Based […]